Navigation Links
EntreMed Commences Phase 2 Study with MKC-1 in Pancreatic Cancer
Date:12/4/2007

Multi-Center Study to Focus on Advanced Cancer Patients

ROCKVILLE, Md., Dec. 4 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today announced that it has commenced a multi-center Phase 2 clinical trial with MKC-1 in patients with advanced pancreatic cancer. The primary objectives of this study will be to determine the antitumor activity of orally-administered MKC-1 in unresectable or metastatic pancreatic cancer patients who have failed at least one prior chemotherapy regimen. The study will also assess the safety, tolerability and overall median survival time of pancreatic cancer patients treated with MKC-1. Massachusetts General Hospital Cancer Center is the lead institution for the study and Eunice Kwak, M.D., Ph.D., Assistant in Medicine, Tucker Gosnell Center for Gastrointestinal Cancers, will serve as the principal investigator.

(Logo: http://www.newscom.com/cgi-bin/prnh/20010620/ENMDLOGO )

MKC-1 is a novel, orally-active cell cycle inhibitor with in vitro and in vivo efficacy against a broad range of human solid tumor cell lines, including multi-drug resistant cell lines. Prior preclinical studies have demonstrated that MKC-1 has significant antitumor activity as both a single agent and in combination with an approved epidermal growth factor/epidermal growth factor receptor (EGF/EGFR) inhibitor in pancreatic cancer models. MKC-1 has also demonstrated broad-acting antitumor effects, including tumor growth inhibition or regression, in multiple preclinical models. MKC-1 has been s
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
2. EntreMed Raises $20 Million to Support Clinical Development Program
3. EntreMed Reports Phase 1 PK and Preclinical Efficacy Results for ENMD-1198
4. EntreMed Shows Increased Survival With MKC-1 in Preclinical Renal Cell Cancer Model
5. Memory Pharmaceuticals Commences Phase 1 Clinical Program for R4996/MEM 63908
6. Sinovac Commences Vaccination on Volunteers for Phase II Clinical Trial on Pandemic Influenza H5N1 Vaccine
7. Sunesis Pharmaceuticals Commences Clinical Trials of SNS-595 and SNS-314
8. Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV
9. Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C
10. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
11. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... DUBLIN , Aug. 20, 2014 Research ... Market Report of Pralmorelin" report to their offering. ... at providing comprehensive data on Pralmorelin globally and regionally ( ... North America , Latin America ... to Pralmorelin This report focuses on three primary ...
(Date:8/20/2014)... Reportlinker.com announces that a new market ... Global Coatings for Medical Devices Industry ... This report analyzes the worldwide markets for Coatings ... following Product Segments: Active Coatings, Protective Coatings, Optical ... comprehensive analytics for the US, Canada ...
(Date:8/20/2014)... LAKE CITY , Aug. 20, 2014 ... revolutionary mobile diagnostic platform during a special event at ... Utah , on September 5, 2014. The event, ... LiveStreamed on the ApolloDx website, www.apollodx.com .    ... transform diagnostic testing," said Jared Bauer , Co-Founder ...
Breaking Medicine Technology:Global Market Report of Pralmorelin 2Global Coatings for Medical Devices Industry 2Global Coatings for Medical Devices Industry 3Global Coatings for Medical Devices Industry 4Global Coatings for Medical Devices Industry 5Global Coatings for Medical Devices Industry 6Global Coatings for Medical Devices Industry 7Global Coatings for Medical Devices Industry 8Global Coatings for Medical Devices Industry 9Global Coatings for Medical Devices Industry 10Global Coatings for Medical Devices Industry 11Global Coatings for Medical Devices Industry 12Global Coatings for Medical Devices Industry 13Global Coatings for Medical Devices Industry 14Global Coatings for Medical Devices Industry 15Global Coatings for Medical Devices Industry 16Global Coatings for Medical Devices Industry 17Global Coatings for Medical Devices Industry 18Global Coatings for Medical Devices Industry 19Global Coatings for Medical Devices Industry 20Global Coatings for Medical Devices Industry 21
... Jan. 25, 2012  Shionogi Inc., the U.S.-based group company ... two studies published online today in the journal ... a randomized, double-blind, placebo-controlled phase III trial , ... drooling due to neurologic conditions demonstrated a significantly better ...
... JUNCTION, N.J., Jan. 25, 2012 Tris Pharma, an ... regarded Big Pharma executive Dr. Mahdi Fawzi to its ... Vice President of R&D including Regulatory Affairs.   ... a huge value as exemplified having many blockbuster drugs ...
Cached Medicine Technology:Study Data Show CUVPOSA® Reduced Chronic Severe Drooling in Patients Ages 3-16 Years-Old with Neurologic Conditions 2Study Data Show CUVPOSA® Reduced Chronic Severe Drooling in Patients Ages 3-16 Years-Old with Neurologic Conditions 3Study Data Show CUVPOSA® Reduced Chronic Severe Drooling in Patients Ages 3-16 Years-Old with Neurologic Conditions 4Study Data Show CUVPOSA® Reduced Chronic Severe Drooling in Patients Ages 3-16 Years-Old with Neurologic Conditions 5Study Data Show CUVPOSA® Reduced Chronic Severe Drooling in Patients Ages 3-16 Years-Old with Neurologic Conditions 6Study Data Show CUVPOSA® Reduced Chronic Severe Drooling in Patients Ages 3-16 Years-Old with Neurologic Conditions 7Study Data Show CUVPOSA® Reduced Chronic Severe Drooling in Patients Ages 3-16 Years-Old with Neurologic Conditions 8Tris Pharma Announces Appointment of Dr. Mahdi Fawzi as Top R&D Executive 2
(Date:8/21/2014)... August 21, 2014 OpsAssure, the ... start-ups selected to participate in the Harbor Accelerator's ... mentorship, curriculum sessions and valuable resources.he Harbor’s goal ... the region. Each start-up selected for the program ... order to help businesses grow quickly, test markets ...
(Date:8/21/2014)... 21, 2014 Recently nominated as the Women’s ... the journey to be the man he is today. Growing ... had a positive look on women, respecting them as professionals and ... gratefulness and thanks to a man who he had the pleasure ... Stern. , KC Armstrong’s name will ring a bell to most ...
(Date:8/21/2014)... Recently, BambooIndustry.com, one of the most famous ... new range of hand scraped bamboo floorings ... an Autumn special offer for these elegant items. According ... a discounted price, up to 25% off; the promotion ... , Providing natural looks and available in different varieties, ...
(Date:8/20/2014)... 2014 Top 10 Best SEO ... companies and announced Bluehost ( http://www.bluehost.com/track/seohosts ), MaxCDN, ... that provide high quality PHP hosting at affordable ... Best SEO Hosting are unbiased and entirely independent, ... information possible. During the recent years, web hosting ...
(Date:8/20/2014)... Illinois (PRWEB) August 21, 2014 On September ... The Walk MS organization connects people living with MS with ... two million dollars and are 85% of the way to ... Junction City, registration begins at 11:30 and the walk starts ... will be available to answer question about chiropractic care and ...
Breaking Medicine News(10 mins):Health News:WRNW1's KC Armstrong Expresses Thanks and Appreciation to Howard Stern 2Health News:Cheap Hand Scraped Bamboo Floorings Recently Unveiled by BambooIndustry.com 2Health News:New Reviews Of Cheap PHP Hosting Companies Unveiled By Top 10 Best SEO Hosting 2Health News:Dr. Kelch of AlignLife North Peoria Supports Peoria Annual Walk MS 2
... Nations has sounded alarm over rising cocaine consumption in ... again in Afghanistan this year reversing the decline witnessed ... the world body urged European Union governments not to ... cocaine, often denying their addiction, and drug abuse by ...
... the age from 16 to 18 to be able to legally ... from getting hooked on cigarettes. ,This call was made ... A report released on the occasion said that the current law ... in 1937, when the dangers of smoking were still unknown. ...
... have died of pneumonia in Orissa's Mayurbhanj district over the ... illness// , officials said Sunday. ,The children, mostly below ... 150 km from the district head quarter of Baripada. ... government hospital at Jashipur by a medical team who visited ...
... India is on the verge of another outsourcing wave: high-end ... menu - over 1,500 tests under one roof. // ... UK are outsourcing laboratory and diagnostic tests to India as ... conduct them here. At the moment, this is generally limited ...
... malaria hospital in Kolkata as here the disease has been ... Born Disease Control Programme. // ,Speaking at ... year in Kolkata only person died of Malaria whereas in ... ,Reprentatives of UP, Bihar, Jharkhand Orissa, Assam and Pondichery participated ...
... sector YES Bank has signed an MoU with a leading ... million dollar health care fund catering to the Indian market ... equity house will run the fund, for which YES Bank ... Asian foray for the fund-house, which is currently Europe-centric., ...
Cached Medicine News:
... 96 temperature cyclers, the gradient block can be ... up to 14 or 22 across the 40- ... of up to 2C between adjacent wells in ... to 12 different annealing temperatures in a single ...
... TC-312 Thermal Cycler is one of the ... & Benefits include: Fast ramping, low ... keypad and program naming, Ready-to-go templates, interchangeable ... Molecular Biology and Diagnostic laboratories and is ...
PTC-100 cycler with Hot Bonnet heated lid,holds sixty 0.5ml tubes...
... with 24-well x 0.2ml sub-ambient block and ... thermistor) Heating rates: up to 3C/second; Accurate ... Excellent uniformity: better than 0.5C within 15 ... programming: directory program storage of up to ...
Medicine Products: